Seeking Alpha

German Merck looks to capitalize on growth in Chinese healthcare spending

  • Merck KGaA (MKGAF) plans to spend $107.67M on a Chinese manufacturing facility.
  • When it comes online in 2017, the plant will produce treatments for diabetes, and cardiovascular disorders for China, where healthcare spending is projected to hit $1T by 2020.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: